TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07643896: ADVANCE Study: Assay Development and Validation for Pre-Natal and Obstetric Conditions

Sponsor: BillionToOne Inc. · Phase: PHASE2 · Area: RARE_ORPHAN · Target Enrollment: 1000 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$16,480,000

Rescue Site Savings

+$10,866,500

Unlock Full NCT07643896 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07643896 Rescue Dossier →